Purple Biotech Ltd (PPBT)
NASDAQ: PPBT · Real-Time Price · USD
3.090
+0.140 (4.75%)
At close: Jun 4, 2026, 4:00 PM EDT
2.870
-0.220 (-7.12%)
After-hours: Jun 4, 2026, 7:15 PM EDT
Purple Biotech Market Cap
Purple Biotech has a market cap or net worth of $6.45 million as of June 4, 2026. Its market cap has decreased by -14.41% in one year.
Market Cap
6.45M
Enterprise Value
-431.03K
1-Year Change
-14.41%
Ranking
Category
Stock Price
$3.09
Market Cap Chart
Since July 14, 2013, Purple Biotech's market cap has increased from $4.97M to $6.45M, an increase of 29.82%. That is a compound annual growth rate of 2.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2026 | 6.45M | -7.76% |
| Dec 31, 2025 | 7.00M | -36.83% |
| Dec 31, 2024 | 11.07M | -48.88% |
| Dec 31, 2023 | 21.67M | -19.15% |
| Dec 29, 2022 | 26.80M | -60.87% |
| Dec 30, 2021 | 68.47M | 2.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Liminatus Pharma | 6.79M |
| Can-Fite BioPharma | 6.70M |
| Silo Pharma | 6.63M |
| SciSparc | 6.62M |
| Cardio Diagnostics Holdings | 6.24M |
| Aptevo Therapeutics | 6.00M |
| Alaunos Therapeutics | 5.91M |
| XTL Biopharmaceuticals | 5.89M |